Floatz logo

Therapeutic Asset Ratings

3,232 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ETOPOSIDE
ALK-Negative Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP4BB (70)
ETOPOSIDE
ALK-Positive Anaplastic Large Cell Lymphoma
Mingzhi ZhangP4BB (70)
ETOPOSIDE
Angioimmunoblastic T-Cell Lymphoma
Eric Jacobsen, MDP4BB (70)
ETOPOSIDE
Lymphoma
Memorial Sloan Kettering Cancer CenterP4BB (70)
ETOPOSIDE
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Alliance for Clinical Trials in OncologyP4BB (70)
EXEMESTANE
Breast Neoplasm
Fujian Cancer HospitalP4BB (70)
FENTANYL
Post-Operative Pain, Non-Human Animal
IVO JURISICP4BB (70)
FILGRASTIM
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer CenterP4BB (70)
FILGRASTIM
Leukemia
Hospital General de MexicoP4BB (70)
FILGRASTIM
Lymphoma
M.D. Anderson Cancer CenterP4BB (70)
FILGRASTIM
Myelodysplastic Syndrome
City of Hope Medical CenterP4BB (70)
FILGRASTIM
Sickle Cell Disease
St. Jude Children's Research HospitalP4BB (70)
Fingolimod
Multiple Sclerosis
BiogenP4BB (70)
Fludarabine
Acute Lymphoblastic Leukemia
Sawa Ito, MDP4BB (70)
Fludarabine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
French Innovative Leukemia OrganisationP4BB (70)
Fludarabine
Lymphoma
National Cancer Institute (NCI)P4BB (70)
Fludarabine
Myelodysplastic Syndrome
City of Hope Medical CenterP4BB (70)
FLUOROURACILUM
Colon Carcinoma
AkesoP4BB (70)
FLUOROURACILUM
Colorectal Carcinoma
City of Hope Medical CenterP4BB (70)
FLUOXETINE
Major Depressive Disorder
University of OxfordP4BB (70)
Folic Acid
Polycystic Ovary Syndrome
Quaid-e-Azam Medical CollegeP4BB (70)
FULVESTRANT
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP4BB (70)
Giapreza
Acute Kidney Injury
The Cleveland ClinicP4BB (70)
Golodirsen
Duchenne Muscular Dystrophy
Rare Disease Research, LLCP4BB (70)
Goserelin
Breast Cancer
TerSera Therapeutics LLCP4BB (70)
Showing 876 to 900 of 3,232 assets
PreviousPage 36 of 130Next